EYPT EyePoint, Inc. - Common Stock
$5,96
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 5, 2026
Zakres 52 tyg.
$4–$19
13% of range
Ocena Analityków
BUY
20 analysts
Cena Docelowa
$37
+514% upside
P/E (TTM)
-1.9
ROE
-84.0%
Marża Zysku Netto
-739.4%
O EyePoint, Inc. - Common Stock Przegląd firmy z Wikipedii
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
Czytaj więcej
EyePoint Pharmaceuticals Inc. (formerly pSivida Corporation) is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
EYPT Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$5.96
Kapitalizacja Rynkowa
$494M
P/E (TTM)
-1.9
EPS (TTM)
$-3.17
Przychody (TTM)
$31M
Stopa dywidendy
—
ROE
-84.0%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$4 – $19
EYPT Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$31M
2017-06-30
→
2025-12-31
EPS
$-3.17
2017-06-30
→
2025-12-31
Wolny przepływ pieniężny
$-243M
2019-12-31
→
2025-12-31
Marże
-739.4%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
EYPT
Mediana porównawcza
P/E (TTM)
-1.9
29.9
P/S (TTM)
15.7
14.4
P/B
1.6
4.4
Price / FCF (Cena / FCF)
-2.0
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
EYPT
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-776.0%
—
Net Profit Margin (Marża Zysku Netto)
-739.4%
0.70%
ROA
-59.3%
-0.55%
ROE
-84.0%
-2.5%
ROIC
-79.6%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
EYPT
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
8.9
3.9
Quick Ratio (Wskaźnik Szybkości)
8.3
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
EYPT
Mediana porównawcza
Revenue YoY (Przychody R/R)
-27.5%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
-8.8%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
-1.8%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
EYPT
Mediana porównawcza
EYPT Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
20 analityków
- Mocne kupno 7 35,0%
- Kup 12 60,0%
- Trzymaj 1 5,0%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
13 analityków · 2026-08-19
Mediana
$37.00
← Poniżej wszystkich celów
$5.96
Niski
$8.00
Wysoki
$68.00
Średni cel
$37.00
+520,8%
Średnia cel
$36.62
+514,4%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.07%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-1.09 | $-0.97 | -0.12% |
| 31 marca 2026 | $-0.99 | $-0.82 | -0.17% |
| 31 grudnia 2025 | $-0.81 | $-0.76 | -0.05% |
| 30 września 2025 | $-0.85 | $-0.80 | -0.05% |
| 30 czerwca 2025 | $-0.85 | $-0.81 | -0.04% |
| 31 marca 2025 | $-0.65 | $-0.67 | 0.02% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| EYPT | $1.51B | -5.8 | -27.5% | -739.4% | -84.0% | — |
| XERS | $1.30B | — | 43.7% | 0.19% | -19.7% | — |
| PAHC | — | 21.5 | 27.4% | 3.7% | 17.8% | 30.9% |
| SPTX | — | — | — | — | — | — |
| ANRO | $568M | -8.1 | — | — | -46.1% | — |
| OMER | $1.23B | -343.6 | — | — | 1.9% | — |
| LXRX | $421M | -8.2 | 60.2% | -101.1% | -39.7% | — |
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31M | $43M | $46M | $41M | $37M | $34M | $20M | $5M | $8M | $2M | $27M | |
| R&D Expense | $221M | $133M | $65M | $50M | $28M | $17M | $15M | $19M | $15M | $14M | $12M | |
| SG&A Expense | $52M | $52M | $40M | $35M | $26M | $21M | $18M | $15M | $11M | $9M | $8M | |
| Operating Expenses | $275M | $189M | $121M | $141M | $92M | $72M | $68M | $44M | $26M | $23M | $20M | |
| Operating Income | $-243M | $-146M | $-75M | $-100M | $-55M | $-37M | $-48M | $-39M | $-19M | $-22M | $6M | |
| Interest Expense | · | · | $1M | $3M | $5M | $7M | $6M | $2M | $0 | $0 | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $19.0K | |
| Other Non-op | $12M | $15M | $7M | $2M | $292.0K | $58.0K | $1M | $420.0K | $91.0K | $72.0K | $22.0K | |
| Pretax Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Income Tax | $279.0K | $90.0K | $83.0K | · | $0 | $0 | $0 | · | $0 | $-155.0K | $96.0K | |
| Net Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | $-86M | $-18M | $-22M | $6M | |
| EPS (Basic) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.22 | |
| EPS (Diluted) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.21 | |
| Shares (Basic) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 29,378,250 | |
| Shares (Diluted) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 30,584,140 | |
| EBITDA | $-241M | $-146M | $-75M | $-100M | $-55M | · | $-48M | · | · | $-22M | $6M |
Bilans 27
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $102M | $100M | $281M | $96M | $179M | $45M | $22M | $45M | $17M | $15M | $19M | |
| Short-term Investments | $204M | $271M | $50M | $49M | $33M | $0 | $0 | $0 | $0 | $14M | $9M | |
| Inventory | $2M | $2M | $4M | $3M | $4M | $5M | $2M | $279.0K | · | · | · | |
| Prepaid Expense | $20M | $9M | $9M | $10M | $4M | $3M | $6M | $1M | $591.0K | $483.0K | $681.0K | |
| Other Current Assets | $2M | $1M | $1M | $782.0K | $517.0K | · | · | · | · | · | · | |
| Current Assets | $329M | $383M | $345M | $173M | $238M | $63M | $42M | $48M | $18M | $30M | $30M | |
| PP&E (Net) | $9M | $8M | $5M | $1M | $476.0K | $630.0K | $357.0K | $288.0K | $313.0K | $290.0K | $338.0K | |
| PP&E (Gross) | $15M | $12M | $8M | $3M | $2M | $2M | $1M | $983.0K | $799.0K | $2M | $2M | |
| Accum. Depreciation | $6M | $4M | $3M | $2M | $1M | $1M | $839.0K | $695.0K | $486.0K | $2M | $2M | |
| Intangibles | · | · | · | $0 | $23M | $25M | $28M | $30M | $364.0K | $1M | $2M | |
| Other Non-current Assets | $6M | $6M | $0 | · | · | · | · | · | · | · | · | |
| Total Assets | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Accounts Payable | $10M | $12M | $7M | $6M | $7M | $5M | $4M | $3M | $1M | $1M | $744.0K | |
| Accrued Liabilities | $24M | $18M | $18M | $16M | $14M | $8M | $7M | $4M | $4M | $4M | $3M | |
| Short-term Debt | · | · | $0 | $10M | $0 | · | · | · | · | · | · | |
| Current Liabilities | $37M | $49M | $63M | $35M | $24M | $15M | $12M | $21M | $5M | $5M | $3M | |
| Capital Leases | $21M | $22M | $5M | $6M | $2M | $2M | $3M | $0 | · | · | · | |
| Other Non-current Liabilities | $87.0K | $205.0K | $0 | $600.0K | $2M | $2M | $3M | $1M | $51.0K | · | · | |
| Total Liabilities | $58M | $82M | $89M | $84M | $79M | $73M | $65M | $41M | $5M | $11M | $9M | |
| Long-term Debt | · | · | · | $30M | · | · | · | · | · | · | · | |
| Total Debt | · | · | $0 | $40M | $37M | · | $47M | · | · | · | · | |
| Common Stock | $83.0K | $68.0K | $49.0K | $34.0K | $34.0K | $18.0K | $11.0K | $95.0K | $39.0K | $34.0K | $29.0K | |
| Retained Earnings | $-1.10B | $-873M | $-742M | $-671M | $-569M | $-511M | $-465M | $-408M | $-311M | $-292M | $-271M | |
| AOCI | $961.0K | $1M | $864.0K | $786.0K | $841.0K | $841.0K | $840.0K | $839.0K | $833.0K | $852.0K | $945.0K | |
| Stockholders' Equity | $306M | $337M | $266M | $96M | $184M | $19M | $8M | $38M | $13M | $21M | $23M | |
| Liabilities + Equity | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Shares Outstanding | 82,826,416 | 68,266,005 | 49,043,074 | 34,082,934 | 33,905,826 | 18,139,981 | 10,941,659 | 95,372,236 | 39,356,999 | 34,172,919 | 29,412,365 |
Przepływy pieniężne 18
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $464.0K | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $28M | $37M | $12M | $14M | $7M | $6M | $5M | · | $2M | $2M | $2M | |
| Deferred Tax | $279.0K | $90.0K | $83.0K | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | $0 | $2M | $2M | $2M | $2M | $981.0K | $724.0K | $756.0K | $770.0K | |
| Restructuring | · | · | · | · | · | $590.0K | · | · | $472.0K | · | · | |
| Other Non-cash | $-39M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-240M | $-126M | $2M | $-65M | $-50M | $-14M | $-57M | · | $-20M | $-16M | $10M | |
| CapEx | $3M | $4M | $3M | $2M | $156.0K | $362.0K | $213.0K | · | $147.0K | $113.0K | $161.0K | |
| Investing Cash Flow | $69M | $-219M | $-3M | $-17M | $-33M | $-362.0K | $-213.0K | · | $14M | $-4M | · | |
| Debt Issued | · | · | $0 | $30M | $0 | · | $50M | · | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $-30M | $-8M | $0 | · | $30M | · | · | · | · | |
| Stock Issued | $173M | $163M | $226M | $0 | · | $50M | $23M | · | $8M | $16M | $0 | |
| Net Stock Activity | $173M | $163M | $226M | · | · | · | $23M | · | · | $16M | · | |
| Financing Cash Flow | $174M | $164M | $187M | $-690.0K | $217M | $37M | $34M | · | $9M | $17M | · | |
| Net Change in Cash | $2M | $-182M | $186M | $-83M | $134M | $23M | $-23M | · | $2M | $-4M | $4M | |
| Taxes Paid | $200.0K | $100.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-243M | $-130M | $-2M | $-67M | $-50M | · | $-57M | · | · | $-16M | $10M | |
| Levered FCF | · | · | $-3M | $-70M | $-56M | · | $-63M | · | · | · | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| Net Margin | -739.4% | -302.4% | -153.8% | -247.0% | -158.1% | · | -278.9% | · | · | -1330.1% | 23.9% | |
| Pretax Margin | -738.5% | -302.2% | -153.7% | -247.0% | -158.1% | · | -278.9% | · | · | -1339.6% | 24.2% | |
| EBITDA Margin | -768.6% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| ROA | -59.3% | -33.8% | -26.4% | -46.1% | -32.9% | · | -75.1% | · | · | -67.3% | 23.1% | |
| ROE | -84.0% | -47.1% | -43.6% | -87.9% | -42.2% | · | -468.1% | · | · | -90.8% | 24.8% | |
| ROIC | -79.6% | -43.4% | -28.2% | -73.2% | -25.0% | · | -86.2% | · | · | -103.5% | 27.1% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 | · | 3.6 | · | · | 5.9 | 8.9 | |
| Quick Ratio | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 | · | 1.9 | · | · | 5.7 | 8.5 | |
| Debt / Equity | · | · | 0.0 | 0.4 | 0.2 | · | 5.7 | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.3 | 0.2 | · | 5.7 | · | · | · | · | |
| Interest Coverage | · | · | -60.2 | -31.2 | -10.1 | · | -7.7 | · | · | · | · |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | · | 0.3 | · | · | 0.1 | 1.0 |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -27.5% | -6.0% | 11.1% | 12.1% | 7.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -8.8% | 5.4% | 10.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -1.8% | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $31M | $43M | $46M | $41M | $37M | $34M | $20M | · | $8M | $2M | $27M | |
| Net Income TTM | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Market Cap | $1.51B | $509M | $1.13B | $119M | $415M | · | $1.70B | · | · | $967M | $1.11B | |
| Enterprise Value | · | · | $802M | $15M | $240M | · | $1.72B | · | · | · | · | |
| P/E | -5.8 | -3.2 | -12.7 | -1.3 | -6.0 | -9.8 | -23.1 | · | -32.9 | -41.6 | 179.5 | |
| P/S | 48.2 | 11.8 | 24.6 | 2.9 | 11.2 | · | 83.3 | · | · | 597.0 | 41.7 | |
| P/B | 4.9 | 1.5 | 4.3 | 1.2 | 2.3 | · | 203.6 | · | · | 46.3 | 47.5 | |
| P / Tangible Book | 4.9 | 1.5 | 4.3 | 1.2 | 2.6 | · | · | · | · | · | · | |
| P / Cash Flow | -6.3 | -4.0 | 604.5 | -1.8 | -8.3 | · | -29.9 | · | · | -59.3 | 107.7 | |
| P / FCF | -6.2 | -3.9 | -704.8 | -1.8 | -8.3 | · | -29.8 | · | · | -58.9 | 109.4 | |
| EV / EBITDA | · | · | -10.7 | -0.1 | -4.3 | · | -36.0 | · | · | · | · | |
| EV / FCF | · | · | -499.0 | -0.2 | -4.8 | · | -30.2 | · | · | · | · | |
| EV / Revenue | · | · | 17.4 | 0.4 | 6.5 | · | 84.5 | · | · | · | · | |
| Earnings Yield | -17.3% | -31.1% | -7.9% | -78.3% | -16.6% | -10.2% | -4.3% | · | -3.0% | -2.4% | 0.56% |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $507.0K | $696.0K | $619.0K | $966.0K | $5M | $24M | $12M | $11M | $9M | $12M | $14M | $15M | $9M | $8M | $11M | $10M | |
| Cost of Revenue | · | · | · | · | · | · | · | $736.0K | $1M | $759.0K | · | $1M | $2M | $640.0K | · | · | |
| R&D Expense | $84M | $72M | $59M | $48M | $55M | $59M | $43M | $30M | $30M | $30M | $18M | $17M | $16M | $14M | $16M | $11M | |
| SG&A Expense | $14M | $15M | $11M | $14M | $12M | $14M | $13M | $13M | $13M | $14M | $11M | $11M | $9M | $9M | $8M | $9M | |
| Operating Expenses | $98M | $88M | $71M | $63M | $68M | $73M | $57M | $43M | $44M | $45M | $30M | $30M | $32M | $29M | $54M | $28M | |
| Operating Income | $-97M | $-87M | $-70M | $-62M | $-62M | $-49M | $-45M | $-33M | $-35M | $-33M | $-16M | $-14M | $-23M | $-22M | $-44M | $-18M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $435.0K | $812.0K | $781.0K | $662.0K | |
| Other Non-op | $3M | $2M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $2M | $2M | $2M | $1M | $1M | $640.0K | |
| Pretax Income | $-94M | · | $-67M | $-60M | $-59M | · | $-41M | $-29M | $-31M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $-50.0K | $186.0K | $0 | $93.0K | $0 | $90.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-94M | $-85M | $-68M | $-60M | $-59M | $-45M | $-41M | $-29M | $-31M | $-29M | $-14M | $-13M | $-23M | $-21M | $-43M | $-18M | |
| EPS (Basic) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| EPS (Diluted) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| Shares (Basic) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| Shares (Diluted) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| EBITDA | $-97M | $-87M | · | $-62M | $-62M | $-49M | · | $-33M | $-35M | $-33M | · | $-14M | $-23M | $-22M | · | $-18M |
Bilans 27
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $110M | $78M | $102M | $75M | $71M | $85M | $100M | $80M | $91M | $271M | $281M | $133M | $140M | $106M | $96M | $75M | |
| Short-term Investments | $70M | $145M | $204M | $129M | $185M | $233M | $271M | $174M | $189M | $28M | $50M | $3M | $3M | $17M | $49M | $82M | |
| Inventory | $2M | $1M | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $4M | |
| Prepaid Expense | $6M | $25M | $20M | $9M | $6M | $6M | $9M | $12M | $10M | $11M | $9M | $9M | $9M | $9M | $10M | $10M | |
| Other Current Assets | $987.0K | $1M | $2M | $899.0K | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $549.0K | $0 | $0 | $782.0K | · | |
| Current Assets | $189M | $250M | $329M | $216M | $265M | $327M | $383M | $269M | $295M | $318M | $345M | $150M | $167M | $146M | $173M | $192M | |
| PP&E (Net) | $10M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $1M | |
| PP&E (Gross) | · | · | $15M | · | · | · | $12M | · | · | · | $8M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $6M | · | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $21M | |
| Other Non-current Assets | $9M | $9M | $6M | $6M | $6M | $6M | $6M | $2M | · | · | $0 | · | · | · | · | · | |
| Total Assets | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Accounts Payable | $17M | $19M | $10M | $10M | $20M | $16M | $12M | $7M | $14M | $7M | $7M | $10M | $11M | $9M | $6M | $6M | |
| Accrued Liabilities | $22M | $16M | $24M | $18M | $11M | $18M | $18M | $14M | $13M | $16M | $18M | $13M | $15M | $10M | $16M | $16M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $5M | $10M | $10M | |
| Current Liabilities | $42M | $37M | $37M | $30M | $33M | $42M | $49M | $49M | $62M | $63M | $63M | $64M | $69M | $27M | $35M | $34M | |
| Capital Leases | $20M | $20M | $21M | $21M | $22M | $22M | $22M | $22M | $22M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | |
| Other Non-current Liabilities | $23.0K | $55.0K | $87.0K | $118.0K | $148.0K | $177.0K | $205.0K | $233.0K | · | · | $0 | $0 | $0 | $600.0K | $600.0K | $600.0K | |
| Total Liabilities | $62M | $58M | $58M | $52M | $55M | $64M | $82M | $82M | $96M | $79M | $89M | $101M | $118M | $76M | $84M | $84M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | · | $30M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $35M | · | $40M | |
| Common Stock | $85.0K | $83.0K | $83.0K | $70.0K | $69.0K | $69.0K | $68.0K | $53.0K | $52.0K | $50.0K | $49.0K | $35.0K | $34.0K | $34.0K | $34.0K | $34.0K | |
| Retained Earnings | $-1.28B | $-1.19B | $-1.10B | $-1.04B | $-978M | $-918M | $-873M | $-832M | $-802M | $-771M | $-742M | $-728M | $-715M | $-693M | $-671M | $-628M | |
| AOCI | $793.0K | $802.0K | $961.0K | $919.0K | $832.0K | $923.0K | $1M | $1M | $792.0K | $836.0K | $864.0K | $841.0K | $842.0K | $843.0K | $786.0K | $653.0K | |
| Stockholders' Equity | $166M | $230M | $306M | $200M | $246M | $298M | $337M | $219M | $228M | $250M | $266M | $59M | $57M | $78M | $96M | $136M | |
| Liabilities + Equity | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Shares Outstanding | 84,981,843 | 83,453,001 | 82,826,416 | 69,569,813 | 68,889,649 | 68,811,357 | 68,266,005 | 53,524,364 | 52,160,305 | 49,885,701 | 49,043,074 | 35,309,432 | 34,306,118 | 34,301,926 | 34,082,934 | 34,072,155 |
Przepływy pieniężne 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $690.0K | $636.0K | $698.0K | $576.0K | $538.0K | $497.0K | $467.0K | $408.0K | $362.0K | $303.0K | $112.0K | · | · | · | · | · | |
| Stock-based Comp | $10M | $12M | $7M | $6M | $7M | $8M | $8M | $7M | $9M | $13M | $4M | $4M | $2M | $3M | $3M | $3M | |
| Deferred Tax | · | · | $369.0K | $0 | · | · | $90.0K | $0 | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $205.0K | $615.0K | |
| Other Non-cash | · | $-8M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-62M | $-81M | $-65M | $-59M | $-63M | $-53M | $-36M | $-39M | $-20M | $-31M | $-23M | $-15M | $57M | $-17M | $-13M | $-13M | |
| CapEx | $1M | $997.0K | $986.0K | $798.0K | $1M | $276.0K | $384.0K | $2M | $900.0K | $1M | $883.0K | $2M | $396.0K | $484.0K | $585.0K | $1M | |
| Investing Cash Flow | $75M | $59M | $-75M | $55M | $48M | $40M | $-96M | $16M | $-160M | $21M | $-47M | $-2M | $13M | $32M | $33M | $6M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | · | $167M | $7M | · | · | $152M | · | · | · | $216M | · | · | · | $0 | · | |
| Financing Cash Flow | $20M | $-3M | $167M | $7M | $238.0K | $-951.0K | $152M | $12M | $329.0K | $115.0K | $218M | $10M | $-37M | $-5M | $-58.0K | $92.0K | |
| Net Change in Cash | $33M | $-24M | $27M | $3M | $-14M | $-15M | $20M | $-11M | $-180M | $-10M | $148M | $-7M | $34M | $10M | $20M | $-7M | |
| Free Cash Flow | · | $-82M | · | · | · | $-53M | · | · | · | $-32M | · | · | · | $-17M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -19207.1% | -12532.5% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| Net Margin | -18633.1% | -12188.5% | · | -6183.4% | -1114.3% | -184.8% | · | -279.0% | -325.3% | -250.6% | · | -83.0% | -251.7% | -275.5% | · | -184.0% | |
| Pretax Margin | -18633.1% | · | · | -6183.4% | -1112.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -19207.1% | -12441.1% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| ROA | -35.7% | -26.1% | · | -21.6% | -19.0% | -13.1% | · | -12.7% | -12.3% | -12.1% | · | -6.6% | -11.2% | -10.6% | · | -9.5% | |
| ROE | -45.8% | -32.1% | · | -28.5% | -25.1% | -16.5% | · | -21.2% | -21.6% | -17.8% | · | -12.9% | -22.0% | -17.3% | · | -16.1% | |
| ROIC | -58.5% | · | · | -31.0% | -25.3% | · | · | · | · | · | · | · | · | · | · | · |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.7 | · | 7.2 | 8.0 | 7.8 | · | 5.5 | 4.7 | 5.1 | · | 2.4 | 2.4 | 5.4 | · | 5.6 | |
| Quick Ratio | 4.3 | 5.9 | · | 6.8 | 7.7 | 7.6 | · | 5.2 | 4.5 | 4.8 | · | 2.1 | 2.1 | 4.5 | · | 4.6 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.3 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | -52.3 | -26.5 | · | -27.8 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.2 | 0.4 | 0.2 | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $31M | · | $41M | $50M | $56M | · | $47M | $45M | $44M | · | $42M | $38M | $39M | · | $40M | |
| Net Income TTM | $-298M | $-249M | · | $-194M | $-165M | $-135M | · | $-102M | $-96M | $-86M | · | $-75M | $-82M | $-80M | · | $-75M | |
| Market Cap | $1.22B | $1.08B | · | $991M | $648M | $373M | · | $428M | $454M | $1.03B | · | $282M | $298M | $101M | · | $270M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $146M | $156M | $13M | · | $152M | |
| P/E | -3.8 | -3.9 | · | -4.9 | -3.6 | -2.3 | · | -4.0 | -4.2 | -10.1 | · | -4.0 | -4.0 | -1.4 | · | -3.7 | |
| P/S | 162.0 | 34.2 | · | 24.0 | 13.0 | 6.6 | · | 9.1 | 10.0 | 23.6 | · | 6.7 | 7.8 | 2.6 | · | 6.7 | |
| P/B | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.0 | |
| P / Tangible Book | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -7.0 | · | · | · | -33.1 | · | · | · | -6.0 | · | · | |
| P / FCF | · | -13.2 | · | · | · | -7.0 | · | · | · | -31.9 | · | · | · | -5.8 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -10.1 | -6.9 | -0.6 | · | -8.3 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -0.8 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 3.5 | 4.1 | 0.3 | · | 3.8 | |
| Earnings Yield | -26.4% | -25.9% | · | -20.3% | -27.8% | -42.8% | · | -25.0% | -23.8% | -9.9% | · | -24.9% | -25.1% | -72.5% | · | -27.2% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $31M | $43M | $46M | $41M | $37M |
| Marża Operacyjna % | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% |
| Zysk netto | $-232M | $-131M | $-71M | $-102M | $-58M |
| Rozwodniony EPS | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | — | — | 0.0 | 0.4 | 0.2 |
| Wskaźnik bieżący | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 |
| Wskaźnik Szybkości | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-243M | $-130M | $-2M | $-67M | $-50M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 217 emitentów · $1.2B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 37 (-18 vs poprzedni kw.) | 20 (-3 vs poprzedni kw.) | 63 (-9 vs poprzedni kw.) | 56 (+18 vs poprzedni kw.) | +8.5M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $118 638 163 | 8 296 375 | 10,19% | Akcje |
| Cormorant Asset Management, LP | $100 100 000 | 7 000 000 | 8,60% | Akcje |
| VANGUARD GROUP INC | $78 353 343 | 4 288 634 | 6,73% | Akcje |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $69 037 426 | 4 827 792 | 5,93% | Akcje |
| Commodore Capital LP | $65 780 000 | 4 600 000 | 5,65% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $51 912 604 | 3 630 252 | 4,46% | Akcje |
| JANUS HENDERSON GROUP PLC | $45 962 750 | 3 565 768 | 3,95% | Akcje |
| Paradigm Biocapital Advisors LP | $41 332 677 | 2 890 397 | 3,55% | Akcje |
| STATE STREET CORP | $33 712 894 | 2 357 545 | 2,90% | Akcje |
| Aberdeen Group plc | $28 725 869 | 2 008 802 | 2,47% | Akcje |
| PERCEPTIVE ADVISORS LLC | $28 600 000 | 2 000 000 | 2,46% | Opcja sprzedaży |
| Balyasny Asset Management L.P. | $25 916 719 | 1 812 358 | 2,23% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $25 269 659 | 1 766 745 | 2,17% | Akcje |
| CITADEL ADVISORS LLC | $25 214 389 | 1 763 244 | 2,17% | Akcje |
| Parkman Healthcare Partners LLC | $18 420 731 | 1 288 163 | 1,58% | Akcje |
| EVENTIDE ASSET MANAGEMENT, LLC | $17 811 837 | 1 245 583 | 1,53% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $16 890 345 | 1 181 143 | 1,45% | Akcje |
| Essex Woodlands Management, Inc. | $15 513 455 | 1 084 857 | 1,33% | Akcje |
| ORBIMED ADVISORS LLC | $15 288 802 | 1 069 147 | 1,31% | Akcje |
| 5AM Venture Management, LLC | $15 015 000 | 1 050 000 | 1,29% | Akcje |
| Rosalind Advisors, Inc. | $14 131 689 | 988 230 | 1,21% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13 885 500 | 971 014 | 1,19% | Akcje |
| HSBC HOLDINGS PLC | $11 918 407 | 833 455 | 1,02% | Akcje |
| Candriam S.C.A. | $11 254 258 | 787 769 | 0,97% | Akcje |
| AMERIPRISE FINANCIAL INC | $11 087 640 | 775 357 | 0,95% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $11 062 981 | 773 635 | 0,95% | Akcje |
| Artia Global Partners LP | $10 969 501 | 767 098 | 0,94% | Akcje |
| Blue Owl Capital Holdings LP | $10 905 094 | 762 594 | 0,94% | Akcje |
| Patient Square Capital LP | $10 296 000 | 720 000 | 0,88% | Akcje |
| Principia Wealth Advisory, LLC | $9 696 346 | 530 725 | 0,83% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9 260 866 | 647 613 | 0,80% | Akcje |
| Sio Capital Management, LLC | $8 910 759 | 623 130 | 0,77% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $7 996 789 | 559 216 | 0,69% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7 899 320 | 552 400 | 0,68% | Opcja kupna |
| Alyeska Investment Group, L.P. | $7 284 463 | 509 403 | 0,63% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $7 151 330 | 500 093 | 0,61% | Akcje |
| Simplify Asset Management Inc. | $5 720 629 | 400 044 | 0,49% | Akcje |
| Ikarian Capital, LLC | $5 296 720 | 370 400 | 0,46% | Opcja kupna |
| Ikarian Capital, LLC | $5 296 720 | 370 400 | 0,46% | Opcja sprzedaży |
| Ghisallo Capital Management LLC | $5 005 000 | 350 000 | 0,43% | Akcje |
| STEMPOINT CAPITAL LP | $4 840 135 | 338 471 | 0,42% | Akcje |
| E Fund Management Co., Ltd. | $4 730 068 | 330 774 | 0,41% | Akcje |
| Jump Financial, LLC | $4 586 825 | 320 757 | 0,39% | Akcje |
| Bleichroeder LP | $4 526 165 | 316 515 | 0,39% | Akcje |
| Woodline Partners LP | $4 296 621 | 300 463 | 0,37% | Akcje |
| Eversept Partners, LP | $4 257 610 | 297 735 | 0,37% | Akcje |
| GOLDMAN SACHS GROUP INC | $4 086 797 | 285 790 | 0,35% | Akcje |
| Rock Springs Capital Management LP | $3 839 822 | 268 519 | 0,33% | Akcje |
| CITIGROUP INC | $3 750 032 | 262 240 | 0,32% | Akcje |
| MYDA Advisors LLC | $3 575 000 | 250 000 | 0,31% | Akcje |
| AXA Investment Managers S.A. | $3 480 640 | 244 427 | 0,30% | Akcje |
| UBS Group AG | $3 373 442 | 235 905 | 0,29% | Akcje |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3 342 639 | 233 751 | 0,29% | Akcje |
| Schonfeld Strategic Advisors LLC | $3 285 853 | 229 780 | 0,28% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3 038 750 | 212 500 | 0,26% | Opcja sprzedaży |
| Propel Bio Management, LLC | $2 741 954 | 191 745 | 0,24% | Akcje |
| Qube Research & Technologies Ltd | $2 704 159 | 189 102 | 0,23% | Akcje |
| Walleye Capital LLC | $2 691 560 | 188 221 | 0,23% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $2 685 554 | 187 801 | 0,23% | Akcje |
| BlackRock, Inc. | $2 649 890 | 185 307 | 0,23% | Akcje |
| CITADEL ADVISORS LLC | $2 559 700 | 179 000 | 0,22% | Opcja sprzedaży |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2 389 303 | 169 334 | 0,21% | Akcje |
| HighVista Strategies LLC | $2 226 567 | 155 704 | 0,19% | Akcje |
| Granahan Investment Management, LLC | $2 136 234 | 149 387 | 0,18% | Akcje |
| Swiss National Bank | $2 034 890 | 142 300 | 0,17% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $1 998 711 | 139 770 | 0,17% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $1 890 660 | 132 214 | 0,16% | Akcje |
| Corient Private Wealth LP | $1 827 526 | 127 799 | 0,16% | Akcje |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $1 740 081 | 121 684 | 0,15% | Akcje |
| BOOTHBAY FUND MANAGEMENT, LLC | $1 548 690 | 108 300 | 0,13% | Opcja kupna |
| BOOTHBAY FUND MANAGEMENT, LLC | $1 548 690 | 108 300 | 0,13% | Opcja sprzedaży |
| DIADEMA PARTNERS LP | $1 520 090 | 106 300 | 0,13% | Opcja kupna |
| SILVERBACK ASSET MANAGEMENT LLC | $1 430 000 | 100 000 | 0,12% | Opcja kupna |
| Squarepoint Ops LLC | $1 401 429 | 98 002 | 0,12% | Akcje |
| RHUMBLINE ADVISERS | $1 393 341 | 97 437 | 0,12% | Akcje |
| CITADEL ADVISORS LLC | $1 357 070 | 94 900 | 0,12% | Opcja kupna |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1 354 752 | 105 101 | 0,12% | Akcje |
| ALGERT GLOBAL LLC | $1 129 557 | 78 990 | 0,10% | Akcje |
| Waverly Advisors, LLC | $1 114 170 | 77 914 | 0,10% | Akcje |
| Cinctive Capital Management LP | $1 037 923 | 72 582 | 0,09% | Akcje |
| Caption Management, LLC | $1 036 750 | 72 500 | 0,09% | Opcja kupna |
| WELLINGTON MANAGEMENT GROUP LLP | $1 035 134 | 72 387 | 0,09% | Akcje |
| GOLDMAN SACHS GROUP INC | $1 002 430 | 70 100 | 0,09% | Opcja kupna |
| DEUTSCHE BANK AG\ | $989 860 | 69 221 | 0,09% | Akcje |
| Bank of New York Mellon Corp | $981 824 | 68 659 | 0,08% | Akcje |
| WOODSTOCK CORP | $979 049 | 68 465 | 0,08% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $971 081 | 75 336 | 0,08% | Akcje |
| BANK OF AMERICA CORP /DE/ | $930 186 | 65 048 | 0,08% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $865 708 | 60 539 | 0,07% | Akcje |
| FOX RUN MANAGEMENT, L.L.C. | $836 950 | 58 528 | 0,07% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $732 017 | 51 190 | 0,06% | Akcje |
| SILVERBACK ASSET MANAGEMENT LLC | $715 000 | 50 000 | 0,06% | Akcje |
| JANE STREET GROUP, LLC | $715 000 | 50 000 | 0,06% | Opcja kupna |
| Erste Asset Management GmbH | $705 500 | 50 000 | 0,06% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $702 545 | 49 129 | 0,06% | Akcje |
| Point72 Asset Management, L.P. | $694 608 | 48 574 | 0,06% | Akcje |
| SBI Okasan Asset Management Co.Ltd. | $644 827 | 45 700 | 0,06% | Akcje |
| MetLife Investment Management, LLC | $621 607 | 43 469 | 0,05% | Akcje |
| JANE STREET GROUP, LLC | $597 954 | 41 815 | 0,05% | Akcje |
| SCOTIA CAPITAL INC. | $597 039 | 41 751 | 0,05% | Akcje |
Insiderzy spółki 25 insiderów · 12 dyrektorzy generalni · 16 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jay S. Duker | President and CEO | 10 lipca 2026 M | 9 594 | 0 | 0 | $0 |
| Nancy Lurker | President & CEO | 12 października 2018 A | 211 700 | 0 | 0 | $0 |
| Paul Ashton | President & CEO | 18 marca 2016 M | 450 741 | 0 | 0 | $0 |
| David Price | Chief Financial Officer | 1 sierpnia 2018 A | — | 0 | 0 | $0 |
| Michael Soja | VP Finance, CFO & Treasurer | 10 września 2008 A | — | 0 | 0 | $0 |
| Ramiro Ribeiro | Chief Medical Officer | 30 czerwca 2026 M | 0 | 0 | 2 | $-73 174 |
| Leonard S Ross | Vice President of Finance and Chief Accounting Officer | 22 grudnia 2018 M | 76 187 | 0 | 0 | $0 |
| Dario A. Paggiarino | Chief Medical Officer | 12 października 2018 F | 29 600 | 0 | 0 | $0 |
| Leonard M Blum | Executive VP and General Manager, US | 14 maja 2018 A | — | 0 | 0 | $0 |
| Debora Jorn | EVP, Corp. & Comm'l Dev. | 27 czerwca 2017 A | — | 0 | 0 | $0 |
| Lori Freedman | VP Corporate Affairs, General Counsel and Secretary | 21 lipca 2016 A | 96 423 | 0 | 0 | $0 |
| Aaron Finlay | Secretary | 18 października 2007 A | — | 0 | 0 | $0 |
| Karen L. Zaderej | Dyrektor | 18 sierpnia 2026 P | 49 100 | 1 | 0 | $52 258 |
| Wendy F Dicicco | Dyrektor | 2 stycznia 2026 A | — | 0 | 0 | $0 |
| ANDO GORAN | Dyrektor | 2 stycznia 2026 A | — | 0 | 0 | $0 |
| Fred Hassan | Dyrektor | 2 stycznia 2026 A | — | 0 | 0 | $0 |
| Michael W Rogers | Dyrektor | 15 listopada 2018 M | 112 500 | 0 | 0 | $0 |
| John B. Landis | Dyrektor | 25 października 2018 A | — | 0 | 0 | $0 |
| David J Mazzo | Dyrektor | 6 września 2018 A | 138 000 | 0 | 0 | $0 |
| Douglas Evan Godshall | Dyrektor | 27 czerwca 2018 M | 12 500 | 0 | 0 | $0 |
| James J Barry | Dyrektor | 7 maja 2018 M | 12 500 | 0 | 0 | $0 |
| Kristine Peterson | Dyrektor | 15 grudnia 2017 A | — | 0 | 0 | $0 |
| SAVAS PETER G | Dyrektor | 3 grudnia 2015 A | — | 0 | 0 | $0 |
| Paul Hopper | Dyrektor | 18 grudnia 2013 A | 10 000 | 0 | 0 | $0 |
| Katherine Woodthorpe | Dyrektor | 27 listopada 2007 A | — | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 5 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| EW Healthcare Partners L.P., EW Healthcare Partners-A L.P., Essex Woodlands Fund IX-GP, L.P., Essex Woodlands IX, LLC, Martin P. Sutter, R. Scott Barry, Ronald Eastman, Petri Vainio, Steve Wiggins ×4 zgłoszenia | 8 grudnia 2023 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 30 sierpnia 2023 | — | Pierwotne zgłoszenie | — | SEC |
| Ocumension Therapeutics | 22 stycznia 2021 | — | Pierwotne zgłoszenie | — | SEC |
| IRS Identification Nos. of above persons (entities only) Pfizer Inc. ×2 zgłoszenia | 26 maja 2017 | — | Pierwotne zgłoszenie | — | SEC |
| Pfizer Inc. | 17 lipca 2007 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 42 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,18% | 11 564 NS | 30 kwietnia 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,61% | 17 260 NS | 30 kwietnia 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,51% | 8 244 SH | 8 sierpnia 2026 | Dziennie |
| IWC · iShares Trust | 0,23% | 262 360 SH | 8 sierpnia 2026 | Dziennie |
| IHE · iShares Trust | 0,22% | 281 199 SH | 8 sierpnia 2026 | Dziennie |
| FSCC · Federated Hermes ETF Trust | 0,12% | 25 180 NS | 31 maja 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,08% | 78 250 NS | 30 kwietnia 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,08% | 4 561 SH | 8 sierpnia 2026 | Dziennie |
| VFMO · VANGUARD WELLINGTON FUND | 0,06% | 86 797 SH | 8 sierpnia 2026 | Dziennie |
| BIB · ProShares Trust | 0,06% | 3 062 NS | 31 maja 2026 | N-PORT |
| IWO · iShares Trust | 0,05% | 592 383 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,05% | 69 310 SH | 8 sierpnia 2026 | Dziennie |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 25 575 NS | 31 maja 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1 980 136 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,03% | 33 518 NS | 30 kwietnia 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 445 218 SH | 8 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 61 360 SH | 8 sierpnia 2026 | Dziennie |
| ISCV · iShares Trust | 0,03% | 15 627 SH | 8 sierpnia 2026 | Dziennie |
| ITWO · ProShares Trust | 0,03% | 3 648 NS | 31 maja 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 378 469 NS | 31 maja 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 34 174 NS | 30 kwietnia 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 2 853 NS | 31 maja 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 152 391 NS | 30 kwietnia 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 3 155 SH | 8 sierpnia 2026 | Dziennie |
| URTY · ProShares Trust | 0,01% | 2 885 NS | 31 maja 2026 | N-PORT |
| IWN · iShares Trust | 0,01% | 120 933 SH | 8 sierpnia 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 901 417 SH | 8 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 11 210 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,01% | 213 549 SH | 8 sierpnia 2026 | Dziennie |
| WSML · iShares Trust | 0,01% | 4 526 SH | 8 sierpnia 2026 | Dziennie |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 2 895 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 72 NS | 31 maja 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 28 026 NS | 31 maja 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3 564 NS | 30 kwietnia 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 111 667 SH | 8 sierpnia 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 21 976 SH | 8 sierpnia 2026 | Dziennie |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 46 188 NS | 31 maja 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10 667 NS | 30 kwietnia 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 41 879 NS | 30 kwietnia 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 13 282 NS | 30 kwietnia 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 643 860 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6 035 SH | 8 sierpnia 2026 | Dziennie |